Skip to content

Zai Lab

US · ZLAB #2554 by market cap Listed 2017
25.31 -0.27 -1.06%
Live - 5344 symbols - heartbeat 7s ago · 2026-10-08 08:16
Pre-market 24.54 -3.04%
After-hours 24.80 -2.02%
Overnight 24.55 -3.00%
Market cap
2.84B
P/B
4.68
EPS
-1.60
Reader sentiment Are you bullish or bearish on ZLAB?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • U.S. Stocks Move | Zai Lab (ZLAB.US) Surges Over 12% as Q2 Product Revenue Rises 11% Sequentially
    Zhitong Finance · 2026/8/6
  • Rating change
    Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $37
    Market Newswire · 2026/2/27
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $53
    Market Newswire · 2026/2/23
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $45
    Market Newswire · 2026/8/7
  • Rating change
    J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $27
    Market Newswire · 2026/5/23
  • Rating change
    J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $39
    Market Newswire · 2026/2/5
  • US Stock Movement | Shares Surge for Two Consecutive Days! Zai Lab (ZLAB.US) Rises Over 10%
    Zhitong Finance · 2026/8/7
  • Rating change
    Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37
    Market Newswire · 2026/8/7
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $47
    Market Newswire · 2026/2/27
  • Rating change
    J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating
    Market Newswire · 2026/4/21
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $44
    Market Newswire · 2026/5/8
  • J.P. Morgan Keeps Their Buy Rating on Zai Lab (ZLAB)
    TipRanks · 2026/9/2
  • J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $36
    Market Newswire · 2026/9/2
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $47
    Market Newswire · 2026/3/10
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)
    TipRanks · 2026/3/26
  • Rating change
    J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $32
    Market Newswire · 2026/3/26
  • Rating change
    BofA Securities Maintains Zai Lab(ZLAB.US) With Hold Rating, Cuts Target Price to $21.8
    Market Newswire · 2026/2/27
  • J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $36
    Market Newswire · 2026/8/27
  • Rating change
    J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $32
    Market Newswire · 2026/3/18
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $53
    Market Newswire · 2026/2/20

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:16:37 · For reference only, not investment advice and not tailored to your situation.